Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-001119-19Phase 2
Phase 2, open-label, single-arm trial of azithromycin in pharyngitis and tonsillitis, sponsored by Pfizer. Primary endpoint: Clinically significant worsening in ocular safety assessments.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-001119-19.